The revision of the EU pharmaceutical legislation is going to be approved and published in a few days. The Commission’s initiative aims at ensuring a future-proof and crisis-resistant medicines regulatory system for Europe.
- What are the expected implications on access for the healthcare stakeholders?
- What is the impact on the sustainability of healthcare systems?
These and other issues will be discussed during this privileged and exclusive talk with Sandra Gallina, Director General - Directorate-General Health and Food Safety (SANTE), European Commission.
AGENDA
10.30 Welcome
Stefano Caselli - Dean, SDA Bocconi
10.45
The revision of the EU pharmaceutical legislation: a talk with Sandra Gallina - Director General - Directorate-General Health and Food Safety (SANTE), European Commission, moderated by Monica Otto - Director Executive Education in Government, Health and Non Profit Division and Pharmaceutical Observatory (OSFAR), CERGAS, SDA Bocconi
11.45 Q&A
12.15 Closing
Amelia Compagni - Director CERGAS, SDA Bocconi
12.30 Networking light lunch.
Join us on campus or online.
